Glen MacDonald
2021
In 2021, Glen MacDonald earned a total compensation of $1.3M as Chief Technology Officer at Eleven Biotherapeutics, a 89% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $135,625 |
|---|---|
| Option Awards | $618,463 |
| Salary | $362,156 |
| Stock Awards | $143,262 |
| Other | $14,486 |
| Total | $1,273,992 |
MacDonald received $618.5K in option awards, accounting for 49% of the total pay in 2021.
MacDonald also received $135.6K in non-equity incentive plan, $362.2K in salary, $143.3K in stock awards and $14.5K in other compensation.
Rankings
In 2021, Glen MacDonald's compensation ranked 7,896th out of 12,415 executives tracked by ExecPay. In other words, MacDonald earned more than 36.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,896 out of 12,415 | 36th |
Division Manufacturing | 3,492 out of 5,505 | 37th |
Major group Chemicals And Allied Products | 1,556 out of 2,375 | 35th |
Industry group Drugs | 1,383 out of 2,096 | 34th |
Industry Pharmaceutical Preparations | 1,024 out of 1,546 | 34th |
Source: SEC filing on April 28, 2022.
MacDonald's colleagues
We found two more compensation records of executives who worked with Glen MacDonald at Eleven Biotherapeutics in 2021.